Mayne Pharma Group Limited (ASX: MYX) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Mayne Pharma Group Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Mayne Pharma Group Limited (ASX: MYX)
Latest News
Share Market News
ASX 200 lunch time report
Share Fallers
Why the Mayne Pharma Group Ltd (ASX:MYX) share price has sunk lower today
Share Market News
Leading brokers name 3 ASX shares to sell today
Share Fallers
Why Mayne Pharma Group Ltd is among 4 shares sinking lower today
Share Fallers
Why the Factor Therapeutics Ltd (ASX:FTT) share price crashed 97% lower today
Share Gainers
Is it too late to buy these high-flying ASX shares?
Share Market News
5 ASX shares that I think are your best bet on Melbourne Cup Day
Share Market News
ALL ORDINARIES finishes higher Monday: 8 shares you missed
Healthcare Shares
The CSL Limited (ASX:CSL) share price is down 24% from its peak – is it time to buy?
Share Gainers
Why these 4 ASX shares have started the week with a bang
Share Market News
What experts are saying about the latest ASX share market meltdown
Value Investing
Why I'm banking on Mayne Pharma Group Ltd (ASX:MYX) shares
Frequently Asked Questions
-
Mayne Pharma made a fully franked cash payment to shareholders in January 2023. Prior to that, the company’s last dividend payout was in 2011.
-
Mayne Pharma Group Ltd listed on the ASX on 29 June 2007.
MYX ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Mayne Pharma Group Limited
Mayne Pharma Group Ltd (ASX: MYX) is a specialty pharmaceutical company focused on commercialising branded and generic pharmaceutical products. Its South Australian manufacturing base produces a portfolio of oral and topical products including tablets, powders, capsules, liquids, and creams.
Mayne Pharma performs limited research and development, typically acquiring off-patent or tail-end pharmaceutical brands. The company also has a contract manufacturing segment and advertises its services in assisting other drug developers in getting their products to market. The Group earns more than 90% of its revenue from the US market.
